5-Fluorouracil-Induced Leukoencephalopathy: Report of Two Cases and Review of Literature
Indian Journal of Medical and Paediatric Oncology · 01.12.2024 · 45 (06) · 546-549
DOI: 10.1055/s-0044-1779488 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Medical and Paediatric Oncology, erschienen am 01.12.2024. Verfasst von Supreeth RN und 2 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
5-fluorouracil (5FU) forms an important component of chemotherapy regimens used in various gastrointestinal (GI) adenocarcinomas and head and neck squamous cell carcinomas. Leukoencephalopathy is a rare adverse effect of 5FU, mediated by hyperammonemia and hyperlactatemia. We report cases of two patients with GI adenocarcinomas who developed neurological symptoms while on 5FU infusion. The neuroimaging and biochemical parameters were suggestive of toxic leukoencephalopathy. They were managed with cessation of the drug and short-term antiepileptic therapy. We also discuss the pathophysiology of this adverse effect and its management.
Zitieren
APA
RN, S., Hingmire, S., & Joshi, A. (2024). 5-Fluorouracil-Induced Leukoencephalopathy: Report of Two Cases and Review of Literature. Indian Journal of Medical and Paediatric Oncology, 45(06), 546-549. https://doi.org/10.1055/s-0044-1779488
Vancouver
RN S, Hingmire S, Joshi A. 5-Fluorouracil-Induced Leukoencephalopathy: Report of Two Cases and Review of Literature. Indian Journal of Medical and Paediatric Oncology. 2024;45(06):546-549. doi:10.1055/s-0044-1779488
BibTeX
@article{RN2024,
author = {RN, Supreeth and Hingmire, Sachin and Joshi, Aniruddha},
title = {5-Fluorouracil-Induced Leukoencephalopathy: Report of Two Cases and Review of Literature},
journal = {Indian Journal of Medical and Paediatric Oncology},
year = {2024},
volume = {45},
number = {06},
pages = {546--549},
doi = {10.1055/s-0044-1779488}
}
EUVIMED